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CB-33. MITOCHONDRIAL LON IS THE FIRST IDENTIFIED 
MITOCHONDRIAL PROTEIN TO MEDIATE HYPOXIC 
ADAPTATION, INVASION, AND TREATMENT RESISTANCE TO 
RADIATION AND TEMOZOLOMIDE IN MALIGNANT GLIOMA 
CELL LINES 
Xing Gong , Yen Vuong , and Daniela A. Bota; UC Irvine 
BACKGROUND: Malignant gliomas are characterized by extensive hypoxic 
areas and innate resistance to treatment. Hypoxia-inducible factor HIF l-0t is an 
indicator of malignant angiogenesis and abnormal proliferation, but less studied 
is HIFl-a involvement in the metabolic shift to glycolysis required for survival 
in low-oxygen environments. One of the HIF 1-0l regulated genes is the mito­
chondrial Lon, which plays an important role in mitochondrial bioenergetics 
and mitochondrial DNA maintenance. Here, we demonstrate that Lon controls 
metabolic adaptation to hypoxia in glioma cells in direct response to HIFl-a 
activation. Also, Lon induction is used by glioma cells to increase resistance 
to radiation and chemotherapy by direct repair of mitochondrial DNA. 
RESULTS: Two malignant glioma cell lines (D-54-MG and U-251-MG) were 
exposed to hypoxia, which increased HIFl-a protein levels. The increase of 
HIFl-a levels was paralleled by a doubling in both the mRNA and the 
protein Lon levels, while HIF 1-a down-regulation was associated with a 
brisk decrease of Lon expression. Lon protease up-regulation in D54-MG 
cells caused increased invasion and resistance to starvation. Treatment with 
temozolomide (TMZ) led to a four-fold induction of Lon, while Lon down­
regulation led to increased sensitivity to TMZ. TMZ-resistant lines D54-TR 
and U251-TR had twice the level of Lon of their parent TMZ-sensitive lines. 
Lon protease in the D54-MG cells induced resistance to TMZ at levels 
similar to that of the resistant line D54-TR. D54 cells with Lon over-expression 
also had increased resistance to radiation. Both the radiation and TMZ resist­
ance in the D54 MG/Lon over-expression cells was caused by an increase in 
the repair of the treatment-induced mitochondrial DNA damage. 
CONCLUSIONS: The data presented show that Lon is one of the principal 
mediators connecting hypoxia with invasion, resistance to starvation, 
chemo-resistance, and radio-resistance, supporting our current research of 
Lon inhibition as a possible therapeutic target in malignant gliomas. 
